CClinicalTrials.gg
CompletedNCT00843466Updated Sep 10, 2018Results posted

Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis

An interventional study of Mild, moisturizing hand cleanser in Hand Dermatosis, sponsored by Wake Forest University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-09-10.

Sponsored by Wake Forest University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to find out if the use of a hand cleanser that adds moisture to the skin will help improve skin rashes caused by frequent hand washing (hand dermatitis).

Read the detailed description

The objective of this protocol is to evaluate compatibility and potential benefits of daily use of a marketed mild, moisturizing hand cleanser for subjects/patients who experience mild to moderate hand dermatitis induced by frequent cleansing.

02

Conditions studied

  • Hand Dermatosis

Keywords

  • Hand dermatitis
03

In context

Dermatitis

1,435 studies on the registry are indexed under Dermatitis; 131 are open to participants now.

This study's enrollment of 46 is below the median of 64 across 1,131 interventional studies indexed under Dermatitis.

Browse Dermatitis studies →

Lead sponsor

Wake Forest University is the lead sponsor of 116 studies on the registry; 7 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 27 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Between 18 and 65 years of age
  • In general good health
  • Hands free of cuts and abrasions
  • Agree to adhere to the requirements listed in the informed consent
  • Willing and able to use a mild, moisturizing, non-antibacterial cleanser for all hand washing purposes for the duration of the test period
  • Willing to refrain from participating in any other clinical research trial for the duration of the study

Exclusion criteria

Exclusion Criteria:

  • Documented allergies to study product components, soaps, latex, or fragrances
  • History of the following conditions which may affect the response of the skin or the interpretation of the results: insulin dependent diabetes, or peripheral vascular diseases
  • Participating in a concurrent clinical study involving treatment of your hands
  • Currently using a prescription medication for hand dermatitis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
46 participants (actual)

Study arms

  • Active comparator
    Mild moisturizing Hand Cleanser

    The test group will be provided with a mild moisturizing hand cleanser for all hand cleansing needs during the duration of the study.

    Other: Mild, moisturizing hand cleanser

  • No intervention
    Current Hand Cleanser

    The control group will continue to use their current cleanser for all hand washing.

Interventions

  • OtherMild, moisturizing hand cleanser

    Hand cleanser ingredient list: Ammonium Lauryl Sulfate, Ammonium Laureth Sulfate, Cocamide MEA, PEG-5 Cocamide Cocamidopropyl Betaine Sodium Lauroyl Sarcosinate Glycerin Petrolatum Soybean Oil Sodium Hydroxypropyl Starch Phosphate Lauric Acid Lauryl Alcohol PEG-14M Guar hydroxypropyl trimonium chloride DMDM Hydantoin; Iodopropynyl Butylcarbamate Etidronic Acid Tetrasodium EDTA Titanium Dioxide Fragrance Sodium Hydroxide Water

06

What researchers measure

Primary outcomes

  1. Investigator Global Assessment

    Changes in global disease severity on a scale from 0-4 with 0 being clear and 4 being severe

    Time frame: Wk 4

07

Results

Posted Mar 16, 2017

Participant flow

Recruitment was from May 22,2007 to May 12, 2008 at Wake Forest University in Winston Salem.

Participant flow — Overall Study
MilestoneTest ProductControl Group (Current Product)
Started2418
Completed2418
Not completed00

Outcome measures

PrimaryInvestigator Global Assessment

Changes in global disease severity on a scale from 0-4 with 0 being clear and 4 being severe

Time frame:
Wk 4
Reported as:
Mean · units on a scale
Investigator Global Assessment
units on a scaleMild Moisturizing Hand Cleanser Test ProductNo Treatment
Investigator Global Assessment1.0 (0.8 to 1.2)1.1 (0.7 to 1.4)

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test Product—0/24 (0%)0/24 (0%)
Control Group (Current Product)—0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Test ProductControl Group (Current Product)Total
<=18 years000
Between 18 and 65 years241842
>=65 years000
Age, Continuous
Age, Continuous(years)Test ProductControl Group (Current Product)Total
Median45 (18 to 78)40 (20 to 65)41 (18 to 78)
Sex: Female, Male
Sex: Female, Male(Participants)Test ProductControl Group (Current Product)Total
Female201434
Male448
Region of Enrollment
Region of Enrollment(participants)Test ProductControl Group (Current Product)Total
United States241842
08

Study locations

1 site
  • Wake Forest University Health Sciences Dermatology
    Winston-Salem, North Carolina 27157, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00843466
Lead sponsor
Wake Forest University
Responsible party
Sponsor
First posted
Feb 13, 2009
Start date
May 2007
Primary completion
Apr 2008
Completion
Nov 2008
Results posted
Mar 16, 2017
Last update
Sep 10, 2018

Study contacts

Alan Fleischer, MD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion